Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$524M |
| 2 |
Meta Platforms (Facebook)
META
|
+$458M |
| 3 |
Otis Worldwide
OTIS
|
+$345M |
| 4 |
T-Mobile US
TMUS
|
+$307M |
| 5 |
AbbVie
ABBV
|
+$280M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$878M |
| 2 |
RTN
Raytheon Company
RTN
|
+$537M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$435M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
Accenture
ACN
|
+$216M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.72% |
| 2 | Healthcare | 14.52% |
| 3 | Financials | 12.98% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MZTI
876
The Marzetti Company
MZTI
$3.11B
| $51.9M | 0.01% |
334,975
+18,057
| +6% | +$2.63M |
|
877
Emergent Biosolutions
EBS
$248M
| $51.8M | 0.01% |
654,665
+13,373
| +2% | +$997K |
|
878
Hanover Insurance
THG
$7.98B
| $51.8M | 0.01% |
510,762
-28,792
| -5% | -$2.82M |
|
879
Strategic Education
STRA
$1.92B
| $51.5M | 0.01% |
335,050
+16,998
| +5% | +$2.65M |
|
|
VRNT
880
DELISTED
Verint Systems
VRNT
| $51.4M | 0.01% |
2,231,739
+46,070
| +2% | +$1.02M |
|
|
KYNB
881
Kyntra Bio
KYNB
$29.4M
| $51.4M | 0.01% |
50,689
+2,804
| +6% | +$2.6M |
|
882
Halozyme
HALO
$12.2B
| $51.2M | 0.01% |
1,910,341
+26,833
| +1% | +$605K |
|
883
LXP Industrial Trust
LXP
$3.57B
| $51.1M | 0.01% |
968,873
+284,946
| +42% | +$14.4M |
|
884
Kinsale Capital Group
KNSL
$8.51B
| $51.1M | 0.01% |
329,138
+26,148
| +9% | +$3.48M |
|
885
Kemper
KMPR
$1.68B
| $51.1M | 0.01% |
704,140
-8,887
| -1% | -$594K |
|
886
First Solar
FSLR
$26.9B
| $51M | 0.01% |
1,031,119
-14,533
| -1% | -$648K |
|
887
Spire
SR
$4.85B
| $50.8M | 0.01% |
773,174
+18,777
| +2% | +$1.34M |
|
|
NVTA
888
DELISTED
Invitae Corporation
NVTA
| $50.8M | 0.01% |
1,675,793
+405,117
| +32% | +$7.07M |
|
889
Tradeweb Markets
TW
$21.6B
| $50.6M | 0.01% |
871,910
+318,125
| +57% | +$18.3M |
|
890
Caesars Entertainment
CZR
$6.14B
| $50.6M | 0.01% |
1,262,144
+285,915
| +29% | +$7.92M |
|
|
PLAN
891
DELISTED
Anaplan, Inc.
PLAN
| $50.5M | 0.01% |
1,115,635
+190,256
| +21% | +$7.97M |
|
892
Radian Group
RDN
$4.93B
| $50.4M | 0.01% |
3,249,277
-39,712
| -1% | -$588K |
|
893
NeoGenomics
NEO
$2.13B
| $50.3M | 0.01% |
1,623,673
+122,233
| +8% | +$3.39M |
|
894
Littelfuse
LFUS
$11.6B
| $50.2M | 0.01% |
294,377
+1,481
| +0.5% | +$225K |
|
|
PRSP
895
DELISTED
Perspecta Inc. Common Stock
PRSP
| $50.2M | 0.01% |
2,159,959
+30,465
| +1% | +$664K |
|
896
Nektar Therapeutics
NKTR
$2.58B
| $50M | 0.01% |
143,875
+3,130
| +2% | +$977K |
|
897
National Health Investors
NHI
$3.65B
| $49.5M | 0.01% |
815,654
+161,951
| +25% | +$8.9M |
|
898
SouthState Bank Corp
SSB
$10.5B
| $49.5M | 0.01% |
1,038,385
+545,099
| +111% | +$28.5M |
|
899
Ziff Davis
ZD
$1.98B
| $49.5M | 0.01% |
899,637
+24,142
| +3% | +$1.58M |
|
900
RBC Bearings
RBC
$18B
| $49.5M | 0.01% |
368,982
+14,036
| +4% | +$1.79M |
|
Similar funds
Geode Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Geode Capital Management held 4,219 positions worth $467B, up 22% from $384B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q2 2020 filing shows 118 new, 2,550 increased, 1,055 reduced and 119 closed positions. Its largest new stake was Otis Worldwide: 6,650,358 shares worth $377M. The largest sale was Allergan plc, an estimated $878M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q2 2020 buy was Otis Worldwide: 6,650,358 shares worth $377M.
- Geode Capital Management added most to Amazon in Q2 2020, an estimated $524M increase.
- Geode Capital Management's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $435M.
- Geode Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $878M.
- Geode Capital Management's ten largest holdings make up 23% of its $467B portfolio in Q2 2020.
- Geode Capital Management opened 118 new positions and closed 119 in Q2 2020.
- Geode Capital Management's portfolio value rose 22% quarter-over-quarter to $467B.
Based on Geode Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.